Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$853M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$805M |
| 3 |
Zoetis
ZTS
|
+$650M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$391M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$177M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 2 |
Amazon
AMZN
|
+$772M |
| 3 |
Becton Dickinson
BDX
|
+$486M |
| 4 |
Medtronic
MDT
|
+$440M |
| 5 |
Vanguard Long-Term Bond ETF
BLV
|
+$373M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Financials | 7.47% |
| 3 | Healthcare | 7.23% |
| 4 | Industrials | 6.4% |
| 5 | Consumer Discretionary | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMF
5026
DELISTED
BNY Mellon Municipal Income
DMF
| $57.1K | ﹤0.01% |
8,366
-2,001
| -19% | -$13.3K |
|
5027
Evolution Petroleum
EPM
$134M
| $57K | ﹤0.01% |
9,276
+1,238
| +15% | +$7.11K |
|
5028
X4 Pharmaceuticals
XFOR
$421M
| $56.9K | ﹤0.01% |
1,365
+198
| +17% | +$5.51K |
|
5029
Latham Group
SWIM
$860M
| $56.8K | ﹤0.01% |
14,333
-293,013
| -95% | -$835K |
|
5030
Bio-Rad Laboratories Class B
BIO.B
| $56.5K | ﹤0.01% |
170
| – | – |
|
5031
Emergent Biosolutions
EBS
$229M
| $56.4K | ﹤0.01% |
22,306
+2,506
| +13% | +$5.65K |
|
5032
Harvard Bioscience
HBIO
$28.8M
| $56.4K | ﹤0.01% |
1,330
+162
| +14% | +$7.28K |
|
5033
Full House Resorts
FLL
$90.5M
| $56.1K | ﹤0.01% |
10,063
+1,339
| +15% | +$6.63K |
|
5034
Fidelity Enhanced International ETF
FENI
$11.3B
| $56K | ﹤0.01% |
1,962
-83
| -4% | -$2.26K |
|
|
TEAD
5035
Teads Holding Co
TEAD
$64.5M
| $55.9K | ﹤0.01% |
14,146
+1,586
| +13% | +$6.34K |
|
5036
VanEck Israel ETF
ISRA
$159M
| $55.8K | ﹤0.01% |
1,487
-18,168
| -92% | -$652K |
|
5037
Ardagh Metal Packaging
AMBP
$2.97B
| $55.7K | ﹤0.01% |
16,244
-3,915
| -19% | -$14K |
|
5038
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.4B
| $55.7K | ﹤0.01% |
2,189
+1,869
| +584% | +$45.7K |
|
5039
BCB Bancorp
BCBP
$155M
| $55.7K | ﹤0.01% |
5,328
-5,365
| -50% | -$61.3K |
|
5040
The Joint Corp
JYNT
$123M
| $55.7K | ﹤0.01% |
4,262
+568
| +15% | +$5.88K |
|
5041
Guggenheim Strategic Opportunities Fund
GOF
$2.26B
| $55.6K | ﹤0.01% |
3,881
-3,708
| -49% | -$51.5K |
|
5042
JPMorgan International Research Enhanced Equity ETF
JIRE
$11.3B
| $55.3K | ﹤0.01% |
883
+474
| +116% | +$28.3K |
|
5043
Princeton Bancorp
BPRN
$288M
| $55.3K | ﹤0.01% |
1,795
+232
| +15% | +$7.46K |
|
5044
RE/MAX Holdings
RMAX
$243M
| $55.1K | ﹤0.01% |
6,287
+721
| +13% | +$6.95K |
|
5045
PUT
Expedia Group
EXPE
$37.7B
| $55.1K | ﹤0.01% |
+400
| New | +$56.9K |
|
5046
Banco de Chile
BCH
$21B
| $54.8K | ﹤0.01% |
2,462
-17,791
| -88% | -$400K |
|
5047
Dimensional International Small Cap Value ETF
DISV
$5.12B
| $54.6K | ﹤0.01% |
2,009
| – | – |
|
|
ESSA
5048
DELISTED
ESSA Bancorp
ESSA
| $54.4K | ﹤0.01% |
2,985
+309
| +12% | +$5.7K |
|
5049
FT Vest US Equity Moderate Buffer ETF July
GJUL
$406M
| $54.4K | ﹤0.01% |
+1,606
| New | +$52.9K |
|
5050
RCM Technologies
RCMT
$205M
| $54.3K | ﹤0.01% |
2,543
-1,170
| -32% | -$32.3K |
|
Similar funds
Wells Fargo's Q1 2024 Portfolio in Review
As of Q1 2024, Wells Fargo held 7,849 positions worth $415B, up 8.3% from $383B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Wells Fargo's Q1 2024 filing shows 356 new, 3,866 increased, 2,176 reduced and 456 closed positions. Its largest new stake was FT Vest US Equity Buffer ETF July: 970,130 shares worth $43.1M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.03B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
- Wells Fargo's largest Q1 2024 buy was FT Vest US Equity Buffer ETF July: 970,130 shares worth $43.1M.
- Wells Fargo added most to Starbucks in Q1 2024, an estimated $853M increase.
- Wells Fargo's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.03B.
- Wells Fargo fully exited Splunk Inc in Q1 2024, selling an estimated $43.1M.
- Wells Fargo's ten largest holdings make up 19% of its $415B portfolio in Q1 2024.
- Wells Fargo opened 356 new positions and closed 456 in Q1 2024.
- Wells Fargo's portfolio value rose 8.3% quarter-over-quarter to $415B.
Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.